Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNMX vs. IXJ: which is better?

Bottom line

GNMX vs IXJ: the short answer

GNMX (Corgi Genomics & Precision Medicine ETF) and IXJ (iShares Global Healthcare ETF) are both etfs.

Updated Nov 19, 2026

GNMX vs IXJ side by side

GNMXIXJ
TypeETFETF
Fund familyCorgi Genomics & Precision MedicineiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.38%
Annual cost per $10k—$38
10-yr cost on $10k (prospectus)—$480
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+14.9%
5-yr return (annualized)—+6.4%
10-yr return (annualized)—+8.2%
Best quarter—+13.6%
Worst quarter—−11.8%
Net assets (fund)—$3.8B
Number of holdings—124
Portfolio turnover—2%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GNMX and IXJ share none of their top holdings.

GNMX top 10

    IXJ top 10

    1. Eli Lilly And Company — 10.93%
    2. Johnson & Johnson — 7.04%
    3. Abbvie Inc. — 5.12%
    4. Unitedhealth Group Incorporated — 4.40%
    5. Merck & Co., Inc. — 4.12%
    6. Astrazeneca Plc — 3.76%
    7. Roche Holding AG — 3.75%
    8. Novartis AG — 3.71%
    9. Amgen Inc. — 2.54%
    10. Thermo Fisher Scientific Incorporated — 2.42%

    FAQ

    What is the difference between GNMX and IXJ?
    GNMX (Corgi Genomics & Precision Medicine ETF) and IXJ (iShares Global Healthcare ETF) are both etfs.
    Should I own both GNMX and IXJ?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.